Method for processing signals in a cement bond logging tool
    21.
    发明申请
    Method for processing signals in a cement bond logging tool 有权
    在水泥粘结测井工具中处理信号的方法

    公开(公告)号:US20070070810A1

    公开(公告)日:2007-03-29

    申请号:US11233720

    申请日:2005-09-23

    IPC分类号: G01V1/40

    CPC分类号: G01V1/46

    摘要: A longitudinally segmented acoustic transducer for a cement bond logging (CBL) tool having a plurality of adjoining PZT ring-like segments driven synchronously in parallel by one or more pulses and caused to vibrate in an anti-resonant mode, substantially below the resonant frequency of an individual segment when used in a transmitting application. When used in a receiving application, each of the plurality of transducer rings are caused to vibrate by acoustic signals detected by the transducer array, also in an anti-resonant mode. High speed digital signal processing enables on-depth, high quality data for all azimuths at each depth to be obtained, processed, normalized and either sent to the surface in real time for each 20 Hz firing cycle, as the CBL tool is pulled toward the surface, or stored in a memory module in digital form for later retrieval. Built-in calibration factors used for normalizing the output signals to the operating conditions of use may be accessed at any time.

    摘要翻译: 一种用于水泥结合测井(CBL)工具的纵向分段的声换能器,其具有多个邻接的PZT环形段,其通过一个或多个脉冲并行驱动并且以反谐振模式振动,基本上低于谐振频率 在传送应用程序中使用的单个段。 当在接收应用中使用时,通过由换能器阵列检测的声信号也使多个换能器环中的每一个也以反谐振模式振动。 高速数字信号处理使得能够获得,处理,归一化每个深度的所有方位角的深度,高质量数据,并且在每个20Hz的点火周期内实时地发送到表面,因为CBL工具被拉向 表面或以数字形式存储在存储器模块中以供稍后检索。 可以随时访问用于将输出信号归一化到使用条件的内置校准因子。

    Protein biopolymer markers predictive of type II diabetes
    22.
    发明申请
    Protein biopolymer markers predictive of type II diabetes 审中-公开
    预测II型糖尿病的蛋白质生物聚合物标记物

    公开(公告)号:US20070031979A1

    公开(公告)日:2007-02-08

    申请号:US11580470

    申请日:2006-10-12

    IPC分类号: G01N33/50 G01N33/543

    摘要: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer, predict disease risk assessment, and develop therapeutic avenues against said disease.

    摘要翻译: 本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合,以使特定样品中可验证的生物聚合物的多样性最大化。 然后,在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使得诊断者能够获得表征所述至少一种疾病状态的存在或不存在的能力,以相对于识别所述生物聚合物的存在和/或不存在,预测疾病风险评估以及开发针对所述疾病的治疗途径。

    Method and apparatus for dynamic load balancing over a network link bundle

    公开(公告)号:US20060221974A1

    公开(公告)日:2006-10-05

    申请号:US11097798

    申请日:2005-04-02

    IPC分类号: H04L12/56

    摘要: Techniques for distributing data packets over a network link bundle include storing an output data packet in a data flow queue based on a flow identification associated with the output data packet. The flow identification indicates a set of one or more data packets, including the output data packet, which are to be sent in the same sequence as received. State data is also received. The state data indicates a physical status of a first port of multiple active egress ports that are connected to a corresponding bundle of communication links with one particular network device. A particular data flow queue is determined based at least in part on the state data. A next data packet is directed from the particular data flow queue to a second port of the active egress ports. These techniques allow a more efficient use of a network link bundle.

    Interalpha trypsin inhibitor biopolymer markers indicative of insulin resistance

    公开(公告)号:US20060211146A1

    公开(公告)日:2006-09-21

    申请号:US11439588

    申请日:2006-05-23

    IPC分类号: G01N33/543

    CPC分类号: C07K14/8114 Y10T436/24

    摘要: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer, predict disease risk assessment, and develop therapeutic avenues against said disease.

    Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance

    公开(公告)号:US20060211143A1

    公开(公告)日:2006-09-21

    申请号:US11439577

    申请日:2006-05-23

    IPC分类号: G01N33/543

    摘要: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer, predict disease risk assessment, and develop therapeutic avenues against said disease.

    Complement C3 precursor biopolymer markers predictive of type II diabetes
    27.
    发明授权
    Complement C3 precursor biopolymer markers predictive of type II diabetes 失效
    补充C3前体生物聚合物标志物预测II型糖尿病

    公开(公告)号:US07097989B2

    公开(公告)日:2006-08-29

    申请号:US09993287

    申请日:2001-11-23

    IPC分类号: G01N33/567 A61K38/00

    摘要: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of at least one disease state relative to recognition of the presence and/or the absence of the biopolymer, predict disease risk assessment, and develop therapeutic avenues against the disease.

    摘要翻译: 本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合,以使特定样品中可验证的生物聚合物的多样性最大化。 然后,在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使得诊断者能够获得表征与识别生物聚合物的存在和/或不存在相关的至少一种疾病状态的存在或不存在的能力,预测疾病风险评估以及开发针对该疾病的治疗途径。

    Protein biopolymer markers indicative of alzheimer's disease
    28.
    发明授权
    Protein biopolymer markers indicative of alzheimer's disease 失效
    指示阿尔茨海默病的蛋白质生物聚合物标记物

    公开(公告)号:US07074576B2

    公开(公告)日:2006-07-11

    申请号:US09992672

    申请日:2001-11-23

    IPC分类号: G01N33/567 A61K38/00

    摘要: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of at least one disease state relative to recognition of the presence and/or the absence of the biopolymer, predict disease risk assessment, and develop therapeutic avenues against the disease.

    摘要翻译: 本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合,以使特定样品中可验证的生物聚合物的多样性最大化。 然后,在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使得诊断者能够获得表征与识别生物聚合物的存在和/或不存在相关的至少一种疾病状态的存在或不存在的能力,预测疾病风险评估以及开发针对该疾病的治疗途径。

    Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance
    29.
    发明申请
    Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance 审中-公开
    表示胰岛素抵抗的α型间胰蛋白酶抑制剂生物聚合物标记物

    公开(公告)号:US20060134699A1

    公开(公告)日:2006-06-22

    申请号:US11351461

    申请日:2006-02-10

    IPC分类号: G01N33/53 G01N33/00

    摘要: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of at least one disease state relative to recognition of the presence and/or the absence of the biopolymer, predict disease risk assessment, and develop therapeutic avenues against the disease.

    摘要翻译: 本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合,以使特定样品中可验证的生物聚合物的多样性最大化。 然后,在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使得诊断者能够获得表征与识别生物聚合物的存在和/或不存在相关的至少一种疾病状态的存在或不存在的能力,预测疾病风险评估以及开发针对该疾病的治疗途径。

    Apolipoprotein biopolymer marker indicative of normal human
    30.
    发明申请
    Apolipoprotein biopolymer marker indicative of normal human 失效
    代表正常人的载脂蛋白生物聚合物标记物

    公开(公告)号:US20060084112A1

    公开(公告)日:2006-04-20

    申请号:US09993300

    申请日:2001-11-23

    IPC分类号: G01N33/53

    摘要: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer, predict disease risk assessment, and develop therapeutic avenues against said disease.

    摘要翻译: 本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合,以使特定样品中可验证的生物聚合物的多样性最大化。 然后,在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使得诊断者能够获得表征所述至少一种疾病状态的存在或不存在的能力,以相对于识别所述生物聚合物的存在和/或不存在,预测疾病风险评估以及开发针对所述疾病的治疗途径。